retatrutide clinical trial results 2024 2025 retatrutide weight loss study Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a Eli Lilly infiltrates anti-obesity market
Pay in 4 interest-free payments of $6.24 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6



























